Loading
institutionsInstitution
Champalimaud Foundation, Champalimaud Clinical Centre
Lisbon's private research foundation and clinic, known for advanced breast cancer guidelines, digestive cancer surgery and cancer-neuroscience research.
Also called: Fundação ChampalimaudChampalimaud Centre for the Unknown
Overview
The Champalimaud Centre for the Unknown opened in 2010 on the Lisbon waterfront as a neuroscience and cancer research institute with an attached clinical centre. Fátima Cardoso directs its breast unit and chairs the international ESO-ESMO Advanced Breast Cancer (ABC) consensus guidelines, the digestive unit is a reference for rectal cancer organ preservation and pancreatic surgery, and the radiation oncology department was among the first in Europe to install new-generation stereotactic and MR-guided systems. Research groups study cancer-nervous system interactions, exosome-mediated metastasis (Bruno Costa-Silva), tumour immunology and computational oncology. The foundation also runs the Champalimaud Vision Award and public engagement programmes.
Location
Lisbon, PT
Type
research institute
Archived website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#221 · 26 points (0 Newsweek + 0 NCI + 26 from 13 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Champalimaud Foundation, including child institutions. 297 works · 6,938 citations · 71% open access · 10% clinical trials · 3% reviews.
Oncology works per year
622022
602023
582024
612025
562026
Most works
- Fátima Cardoso46 works
- Amjad C. Parvaiz31 works
- Berta Sousa27 works
- Laura Melina Fernandez25 works
- Markus Wolfgang Büchler24 works
- Ketti Mazzocco23 works
- Martin Loos22 works
- Paula Poikonen‐Saksela21 works
- Ruth Pat‐Horenczyk19 works
- Albino Jorge Oliveira-Maia18 works
Most cited
- Advanced Breast Cancer (ABC) guidelines
- Digestive oncology and rectal organ preservation
- Precision radiotherapy
- Cancer and neuroscience research
Leonor Beleza
President
Foundation governanceHealth policyBiomedical research funding
President of the Champalimaud Foundation in Lisbon, home to the Champalimaud Clinical Centre for cancer care and research.
Teresa Cotta-Dias
Secretary-General for the Champalimaud Clinical Centre
Clinical centre managementCancer care delivery
Secretary-General responsible for the Champalimaud Clinical Centre, the Foundation's cancer-focused clinical arm.
Similar pages
- IdeaA blood test for the pre-metastatic niche
Shares Metastasis is understood least and studied last, Liquid biopsy (ctDNA), HR-positive / HER2-negative breast cancer, Pancreatic ductal adenocarcinoma.
- IdeaBreak the neutrophil DNA nets that catch tumour cells after surgery
Shares Metastasis is understood least and studied last, Liquid biopsy (ctDNA), Pancreatic ductal adenocarcinoma, Colorectal cancer.
- IdeaPerioperative beta-blocker plus COX-2 inhibitor to reduce metastasis after surgery
Shares Metastasis is understood least and studied last, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- IdeaStrip the platelet coat off travelling tumour cells in ctDNA-positive patients
Shares Metastasis is understood least and studied last, Liquid biopsy (ctDNA), HR-positive / HER2-negative breast cancer, Colorectal cancer.
- InstitutionINCLIVA Biomedical Research Institute / Hospital Clínico Universitario de Valencia
Shares European Society for Medical Oncology (ESMO), Liquid biopsy (ctDNA), HR-positive / HER2-negative breast cancer, Pancreatic ductal adenocarcinoma.
- IdeaA test to tell true oligometastatic disease from hidden widespread spread
Shares Metastasis is understood least and studied last, SBRT / SABR (stereotactic radiotherapy), Liquid biopsy (ctDNA), Colorectal cancer.
- IdeaWhen the blood test is positive, hunt for the lesion with sensitive imaging
Shares Metastasis is understood least and studied last, SBRT / SABR (stereotactic radiotherapy), HR-positive / HER2-negative breast cancer, Colorectal cancer.
- IdeaCheap perioperative beta-blocker plus anti-inflammatory to blunt surgical stress
Shares Metastasis is understood least and studied last, HR-positive / HER2-negative breast cancer, Colorectal cancer.